webinar register page

Webinar banner
State of the Art Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
In this free virtual session, experts from the Columbia Pancreas Center will provide updates on new treatments for patients with pancreas cancer. Over the course of the session, presenters will share best practices from Columbia’s renowned, multidisciplinary pancreas cancer team to maximize treatment outcomes while sparing toxicity, as well as exciting new therapies in pancreas cancer on the horizon.

Upon conclusion of this activity, participants will be better able to:
• Recognize the growing role of neoadjuvant treatment in pancreas cancer.
• Discuss the evolution of radiotherapy techniques to treat pancreas cancer
• Discuss surgical management options for patients with borderline resectable and locally advanced pancreatic cancer

Target audience: Regional and national gastrointestinal medical oncologists, surgeons and radiation oncologists, residents, fellows, and other oncology providers, as well as patients and pancreatic cancer advocacy groups.

5:00-5:20 | Gulam Manji, MD, PhD: "Current Neoadjuvant Chemotherapy Landscape for Borderline and Locally Advanced Pancreatic Cancer."
5:20-5:40| David Horowitz, MD: "Advances in Radiotherapy for Borderline Resectable and Locally Advanced Pancreas Cancer"
5:40-6:00 | John Chabot, MD, FACS: "Novel Surgical Techniques in Locally Advanced Pancreatic Cancer"
6:00-6:30|Q+A

This activity has been approved for AMA PRA Category 1 Credit

Jun 15, 2021 05:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: ColumbiaCME.